{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:58:47Z","timestamp":1790848727471,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41577-020-0359-5","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T08:05:53Z","timestamp":1591603553000},"page":"392-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Dissecting antibody-mediated protection against SARS-CoV-2"],"prefix":"10.1038","volume":"20","author":[{"given":"Tomer","family":"Zohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"359_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0897-1","author":"Q-X Long","year":"2020","unstructured":"Long, Q.-X. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-020-0897-1 (2020).","journal-title":"Nat. Med."},{"key":"359_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6284","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science https:\/\/doi.org\/10.1126\/science.abc6284 (2020).","journal-title":"Science"},{"key":"359_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20047365","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.30.20047365 (2020).","journal-title":"medRxiv"},{"key":"359_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virol.2014.02.005","volume":"454\u2013455","author":"F Yasui","year":"2014","unstructured":"Yasui, F. et al. Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus. Virology 454\u2013455, 157\u2013168 (2014).","journal-title":"Virology"},{"key":"359_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123158","volume":"4","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti\u2013spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","journal-title":"JCI Insight"},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1128\/JVI.00671-11","volume":"85","author":"M Jaume","year":"2011","unstructured":"Jaume, M. et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway. J. Virol. 85, 10582\u201310597 (2011).","journal-title":"J. Virol."},{"key":"359_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","author":"T Gao","year":"2020","unstructured":"Gao, T. et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.29.20041962 (2020).","journal-title":"medRxiv"},{"key":"359_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13263","author":"A Soresina","year":"2020","unstructured":"Soresina, A. et al. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr. Allergy Immunol. https:\/\/doi.org\/10.1111\/pai.13263 (2020).","journal-title":"Pediatr. Allergy Immunol."},{"key":"359_CR9","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1073\/pnas.2004168117","volume":"117","author":"K Duan","year":"2020","unstructured":"Duan, K. et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc. Natl Acad. Sci. USA 117, 9490\u20139496 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0359-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0359-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:59:52Z","timestamp":1684605592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-0359-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-0359-5","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"1 June 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.A. is a founder of Seromyx Inc. T.Z. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}